Alkeran
Alkeran

4.56
For patients managing oncology care and women's health, this generic medicine impairs DNA replication within target cells. Slows malignant cell growth.


Ingredient
Availability
In Stock
Delivery Time
Airmail (14-21 days) | Trackable (5-9 days)
Shipped in a discreet, unmarked envelope with all required documents enclosed.

Product Sheet

Active Ingredient(s)
Melphalan
Reference Brand
Melphalan
Product Origin
Generic Alternative
Reference Manufacturer
GlaxoSmithKline
Product Form
Tablet
Regulatory Classification
Prescription Only Medicine
Primary Category
Pain Relief, Oncology Support
Product Category
Alkylating Agent
Pharmacological Class
Nitrogen Mustard
Clinical Indications
Manufacturer Description
Indicated to address neoplastic cells to alleviate tumor burden and support systemic therapeutic protocols.
Mechanism of Action
Alkylates DNA strands, leading to cross-linking of DNA and RNA and inhibiting cellular division in rapidly proliferating tumor cells.
Route of Administration
Oral
Onset Time
2–3 weeks
Duration
6–12 hours
Contraindications
Severe bone marrow depression, Hypersensitivity to melphalan
Severe Adverse Events
Severe bone marrow suppression — requires immediate medical attention, Pulmonary fibrosis — requires immediate medical attention
Common Side Effects
Nausea, Vomiting, Fatigue
Uncommon Side Effects
Myelosuppression, Thrombocytopenia, Anemia
Drug Interactions
Cyclosporine, Carmustine
Pregnancy Safety Warnings
TGA Category D: High risk of fetal harm. Do not use in pregnancy. Breastfeeding: Contraindicated.
Age Restrictions
Approved for adults.
Storage Guidelines
Store between 2°C and 8°C.
Related Products
Information related to Alkeran is compiled and periodically reviewed with reference to established medical sources and prescribing guidance. Content is provided for general reference and should be confirmed with a registered healthcare professional before use.
Categories
where to purchase OCP Medication Online - Levonorgestrel Emergency Contraception